Efficacy and Safety of a Magnetic Device for Temporary Management of Blepharoptosis: Single-Arm Open-Label Trial.
Ching-Feng Lien, Bor-Shyh Lin, Tzong-Ming Wu...
https://pubmed.ncbi.nlm.nih.gov/40671431Actively Recruiting
Led by E-DA Hospital · Updated on 2025-05-14
40
Participants Needed
2
Research Sites
N/A
Total Duration
E
E-DA Hospital
Lead Sponsor
N
National Yang Ming Chiao Tung University
Collaborating Sponsor
Researchers are studying a new feedback-enabled magnetic device designed to temporarily manage blepharoptosis, a condition where the upper eyelid droops. The study aims to evaluate how well the device improves eyelid height, symmetry of blinks, and reduces symptoms like visual field obstruction, blurred vision, and discomfort on the eyelid and surrounding skin. The safety and effectiveness of this device will be compared with outcomes from patients who undergo surgery for the same condition. The device includes near-infrared sensors, a magnetic actuator, an iron sheet for attaching to the affected eyelid, and a biosignal module. During the study, participants will use the device for sessions lasting about 120 minutes each. Researchers will measure the distance the eyelid lifts and assess muscle activity related to eyelid movement. Both subjective sensations and any side effects will be monitored to evaluate the device’s performance. Participants will have their eyelid measurements taken before and after using the device, along with assessments of visual field changes and muscle activity. These evaluations occur shortly after device use and include checking for any skin irritation or discomfort. The study also includes follow-up examinations comparing device use with surgical treatment outcomes at one and six months. The total participation time for each device use session is about two hours, with longer-term follow-up for surgical cases.
CONDITIONS
A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 2 hours per device testing session
Participants use the feedback-enabled magnetic device for temporary management of blepharoptosis. The device testing lasts approximately 120 minutes each time, and efficacy and safety are assessed during and shortly after use.
1 visit (in-person) for device testing and immediate assessments
Duration - 6 months
Participants who undergo surgical intervention are evaluated for efficacy and complications at 1 month and 6 months after surgery.
2 visits (in-person) at 1 month and 6 months post-surgery
Total: 2 locations
1
E-Da Hospital
Kaohsiung City, Taiwan, 82445
Actively Recruiting
2
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan
Actively Recruiting
C
Ching-Feng Lien, MD, PhD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ching-Feng Lien, Bor-Shyh Lin, Tzong-Ming Wu...
https://pubmed.ncbi.nlm.nih.gov/40671431